Ivan Bodis-Wollner and Robert C. Collins, editorial committee cochairs, quarterly, $150 (institutions), $60 (individuals), New York, NY, Wiley-Liss, 1993-.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The 1990s have brought significant advances in the understanding of the function and dysfunction of the human brain. Theoretical concepts developed by neuroscientific researchers will form the foundation for the treatment of "some of society's most devastating disorders," assert the chairs of the editorial committee of this new review journal.
Clinical Neuroscience was created to communicate the latest research findings from neurology, psychiatry, neurobiology, and pharmacology to both researchers and clinicians. Each issue focuses on timely topics—Alzheimer's disease, AIDS, multiple sclerosis, schizophrenia—developed under the direction of a guest editor who assigns articles and writes an introductory overview of the subject.
This topical emphasis is similar to two other major review publications in the field, Neurologic Clinics and Seminars in Neurology. The first issues of Clinical Neuroscience deal with Alzheimer's disease, Parkinson's disease, and the neuroscience of depression.
Bensing KM, Geldmarcher DS. Clinical Neuroscience. JAMA. 1994;272(13):1078. doi:10.1001/jama.1994.03520130120047